Phase 1 Traverse Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Phase 1 Traverse Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Phase 1 Traverse Study Today - Breaking & Trending Today

Dr Srour on the Phase 1 TRAVERSE Study of ALLO-316 in Metastatic Clear Cell RCC

Published: April 18, 2023

Samer A. Srour, MB, ChB, MS, discusses the study design of the phase 1 TRAVERSE study, and key data on the use of ALLO-316 in patients with advanced or metastatic clear cell renal cell carcinoma.

Source: onclive.com

Related Topics:

United StatesSamera SrourDepartment Of Stem Cell TransplantationDivision Of Cancer MedicineUniversity Of Texas Md Anderson Cancer CenterStem Cell TransplantationCellular TherapyCancer MedicineCancer CenterB ChbThe University Of Texas Md Anderson Cancer CenterPhase 1 Traverse StudyAllo 316Dvanced Or Metastatic Clear Cell Renal Carcinoma